<DOC>
	<DOCNO>NCT00097591</DOCNO>
	<brief_summary>The sponsor investigational drug develop prasugrel ( also know CS-747 ) possible treatment patient acute coronary syndrome ( heart attack chest pain ) need , expect need , percutaneous coronary intervention ( PCI ; also call balloon angioplasty ) . Prasugrel compare Clopidogrel determine drug well reduce death , future heart attack , stroke .</brief_summary>
	<brief_title>A Comparison Prasugrel ( CS-747 ) Clopidogrel Acute Coronary Syndrome Subjects Who Are Undergo Percutaneous Coronary Intervention</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>A person diagnose acute coronary syndrome undergo percutaneous coronary intervention . A person legal age 18 mentally competent provide sign write informed consent . If woman childbearing potential ( i.e. , menopause ) , must test negative pregnancy agree use reliable method birth control . A person ischemic stroke within last 3 month hemorrhagic stroke time past . A person active internal bleeding history bleed disorder . Individuals increase risk bleeding base laboratory criterion evaluate treatment physician medication cause bleeding . A person liver disease ; example , cirrhosis . A person condition alcoholism , mental illness , drug dependent . A person cardiogenic shock , refractory ventricular arrhythmia , congestive heart failure ( class IV ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>